Keith S. Kaye
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
691
Citations
34,728
Est. group size
~9
Recurring co-author estimate
Active years
47
Publishing since 1980
Typically publishes in teams of ~9 · 13% small-team papers (≤3 authors) · across 55 venues
- Sports fever! Getting the ball rolling to prevent infections at the World Cup™ and beyond
Antimicrobial Stewardship & Healthcare Epidemiology · 2026
- Early Symptom Response in Patients With Uncomplicated Urinary Tract Infection Treated With Gepotidacin or Nitrofurantoin: Pooled Analysis From Two Pivotal Phase 3 Studies
Clinical Infectious Diseases · 2026
- Sustaining Success: Supporting Principles of Infection Prevention and Control in Facility Management and Planning
Infectious Disease Clinics of North America · 2026
- Sports fever! Getting the ball rolling to prevent infections at the World Cup™ and beyond
UNC Libraries · 2026
- Patient and Provider Differences between Treated and Untreated Cases of PCR (+) Toxin EIA (-) Clostriodes difficile Infections
Figshare · 2026
- Patient and Provider Differences between Treated and Untreated Cases of PCR (+) Toxin EIA (-) Clostriodes difficile Infections
Figshare · 2026
- The Role of Particulate Matter in Surgical Site Infection Pathogenesis: A Scoping Review
Journal of Hospital Infection · 2026
- Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis
Clinical Infectious Diseases · 2025
- Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales
Future Microbiology · 2025
- How do I manage difficult-to-treat Pseudomonas aeruginosa infections? Key questions for today’s clinicians
Clinical Microbiology and Infection · 2025
- Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>
Clinical Microbiology Reviews · 2025
- Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic Review
Clinical Infectious Diseases · 2025
- The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens
Clinical Infectious Diseases · 2025
- Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity
Clinical Pharmacology & Therapeutics · 2025
- A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities
Scientific Reports · 2025
- Open Forum Infectious Diseases×132
- Clinical Infectious Diseases×41
- Infection Control and Hospital Epidemiology×24
- Antimicrobial Agents and Chemotherapy×19
- Infectious Disease Clinics of North America×18
- Walaiporn Wangchinda
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jason M. Pogue
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Samuel L Aitken
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Karen Bush
Biochemistry, Genetics and Molecular Biology · Indiana University
- Paul Lephart
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile